Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-008690
Filing Date
2025-03-20
Accepted
2025-03-20 17:08:16
Documents
2
Period of Report
2025-03-18

Document Format Files

Seq Description Document Type Size
1 form3-03202025_090312.html 3  
1 form3-03202025_090312.xml 3 2397
2 ex24-03202025_090313.htm EX-24 7276
  Complete submission text file 0001415889-25-008690.txt   11091
Mailing Address C/O NEVRO CORP. 1800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address
Galligan Andrew H (Reporting) CIK: 0001417976 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41259 | Film No.: 25757380

Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Issuer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)